vs

Side-by-side financial comparison of CITIUS ONCOLOGY, INC. (CTOR) and GREENPOWER MOTOR Co INC. (GP). Click either name above to swap in a different company.

GREENPOWER MOTOR Co INC. is the larger business by last-quarter revenue ($7.2M vs $3.9M, roughly 1.8× CITIUS ONCOLOGY, INC.). GREENPOWER MOTOR Co INC. runs the higher net margin — -65.6% vs -140.3%, a 74.7% gap on every dollar of revenue.

Citius Oncology, Inc. is a late-stage biopharmaceutical company focused on developing innovative targeted therapies for cancer patients. Its core pipeline covers treatments addressing unmet medical needs in hematologic malignancies and solid tumors, primarily serving North American and global oncology care markets.

GreenPower Motor Company Inc. is a Canadian electric bus manufacturer and distributor in North America. The company fabricates multiple zero-emission models, including transit buses, school buses, and double decker buses. GreenPower headquarters are in Vancouver, British Columbia, with a sales office in Rancho Cucamonga, California; an assembly facility in Porterville, California; and a production facility in South Charleston, West Virginia. Its stock is traded on Nasdaq the United States.

CTOR vs GP — Head-to-Head

Bigger by revenue
GP
GP
1.8× larger
GP
$7.2M
$3.9M
CTOR
Higher net margin
GP
GP
74.7% more per $
GP
-65.6%
-140.3%
CTOR

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
CTOR
CTOR
GP
GP
Revenue
$3.9M
$7.2M
Net Profit
$-5.5M
$-4.7M
Gross Margin
80.0%
14.6%
Operating Margin
-133.2%
Net Margin
-140.3%
-65.6%
Revenue YoY
-11.5%
Net Profit YoY
16.9%
-2.1%
EPS (diluted)
$-0.06
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTOR
CTOR
GP
GP
Q4 25
$3.9M
Q4 24
$7.2M
Q3 24
$5.3M
Q2 24
$3.0M
Q4 23
$8.2M
Q3 23
$8.4M
Q2 23
$17.6M
Q4 22
$12.8M
Net Profit
CTOR
CTOR
GP
GP
Q4 25
$-5.5M
Q4 24
$-4.7M
Q3 24
$-4.7M
Q2 24
$-5.4M
Q4 23
$-4.6M
Q3 23
$-4.3M
Q2 23
$-2.8M
Q4 22
$-3.4M
Gross Margin
CTOR
CTOR
GP
GP
Q4 25
80.0%
Q4 24
14.6%
Q3 24
8.6%
Q2 24
7.4%
Q4 23
16.6%
Q3 23
14.6%
Q2 23
15.9%
Q4 22
17.4%
Operating Margin
CTOR
CTOR
GP
GP
Q4 25
-133.2%
Q4 24
Q3 24
Q2 24
Q4 23
Q3 23
Q2 23
Q4 22
Net Margin
CTOR
CTOR
GP
GP
Q4 25
-140.3%
Q4 24
-65.6%
Q3 24
-87.9%
Q2 24
-179.8%
Q4 23
-56.9%
Q3 23
-50.4%
Q2 23
-16.0%
Q4 22
-26.4%
EPS (diluted)
CTOR
CTOR
GP
GP
Q4 25
$-0.06
Q4 24
$-0.17
Q3 24
$-0.18
Q2 24
$-0.21
Q4 23
$-0.19
Q3 23
$-0.17
Q2 23
$-0.11
Q4 22
$-0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTOR
CTOR
GP
GP
Cash + ST InvestmentsLiquidity on hand
$7.3M
$621.1K
Total DebtLower is stronger
Stockholders' EquityBook value
$58.4M
$2.1M
Total Assets
$110.0M
$37.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTOR
CTOR
GP
GP
Q4 25
$7.3M
Q4 24
$621.1K
Q3 24
$116.9K
Q2 24
$528.3K
Q4 23
$4.0M
Q3 23
$2.0M
Q2 23
$1.5M
Q4 22
$609.6K
Stockholders' Equity
CTOR
CTOR
GP
GP
Q4 25
$58.4M
Q4 24
$2.1M
Q3 24
$4.2M
Q2 24
$8.6M
Q4 23
$18.1M
Q3 23
$22.3M
Q2 23
$26.2M
Q4 22
$27.3M
Total Assets
CTOR
CTOR
GP
GP
Q4 25
$110.0M
Q4 24
$37.4M
Q3 24
$39.4M
Q2 24
$43.5M
Q4 23
$50.2M
Q3 23
Q2 23
Q4 22

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTOR
CTOR
GP
GP
Operating Cash FlowLast quarter
$-7.4M
$-1.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTOR
CTOR
GP
GP
Q4 25
$-7.4M
Q4 24
$-1.1M
Q3 24
$-1.3M
Q2 24
$-3.2M
Q4 23
$1.4M
Q3 23
$-5.4M
Q2 23
$7.8M
Q4 22

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons